Indivior Pharmaceuticals Inc (INDV) Stock Analysis & Investment Frameworks
Indivior Pharmaceuticals Inc (INDV) stock analysis on Invetso. Review Indivior Pharmaceuticals Inc’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Indivior Pharmaceuticals Inc Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
Indivior Pharmaceuticals Inc Key Financial Metrics
- Market Cap: $4.53B
- Revenue: $1.24B
- P/E Ratio: 21.6
- ROE: -352.94%
- ROIC: 95.41%
- Dividend Yield: 22.41%
About Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.